phenylalanine and Myeloproliferative Disorders

phenylalanine has been researched along with Myeloproliferative Disorders in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (52.00)	29.6817
2010's	12 (48.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Backman, SB; Bui, H; Hatzakorzian, R; Schricker, T	1
Eisenhower, C; Erlich, P; Ferrari, A; Irvin-Barnwell, EA; Patel, MD; Roda, P; Tang, X	1
Dirnhofer, S; Duek, A; Grisouard, J; Hao-Shen, H; Kubovcakova, L; Shimizu, T; Skoda, RC	1
Chang, JG; Ho, CM; Lin, CY; Peng, CT; Tamamyan, G; Yang, SF	1
Carillo, S; Ellard, S; Fehse, B; Girodon, F; Hammond, E; Hanlon, K; Harrivel, V; Hermans, M; Hermouet, S; Herrmann, R; Jelinek, J; Kröger, N; Lippert, E; Marzac, C; Migeon, M; Mounier, M; Pietra, D; Prchal, JT; Reading, NS; Richard, C; Skoda, RC; Sobas, M; Swierczek, S; Ugo, V	1
Girodon, F; Gisslinger, H; Hao-Shen, H; Hermouet, S; Jäger, R; Kralovics, R; Looser, R; Schaub, FX; Skoda, RC; Tichelli, A	1
Ageno, W; Appio, L; Brivio, L; Campiotti, L; Crowther, M; Dentali, F; Grandi, AM; Squizzato, A	1
Cao, Q; Gery, S; Gueller, S; Koeffler, HP; Tefferi, A; Xing, H	1
Amyere, M; Girardot, M; Knoops, L; Michaux, L; Selleslag, D; van Hees, J	1
Bay, JO; Berger, MG; Chaleteix, C; Fleury, J; Gouas, L; Goumy, C; Ledoux-Pilon, A; Richard-Pebrel, C; Tchirkov, A; Tournilhac, O; Vago, P; Véronèse, L	1
Kirito, K; Koda, AH; Komatsu, N; Morishita, S; Noda, N; Sekiguchi, Y; Tsuneda, S	1
Barosi, G; Bergamaschi, G; Carolei, A; Catarsi, P; Poletto, V; Primignani, M; Rosti, V; Spolverini, A; Vannucchi, AM; Villani, L	1
Iványi, JL; Marton, E; Plander, M	1
Bisht, KS; Cogle, CR; Gali, M; Keserü, GM; Kirabo, A; Majumder, A; Park, SO; Reinhard, MK; Sayeski, PP; Wamsley, HL; Zhao, ZJ	1
Biamonte, F; Biasiolo, M; Bisognin, A; Bortoluzzi, S; Guglielmelli, P; Manfredini, R; Norfo, R; Vannucchi, AM	1
Ahmed, W; Betancur, M; Hennighausen, L; Lazarides, K; Patel, N; Van Etten, RA; Walz, C; Zaleskas, VM	1
Agbetiafa, K; Amegbor, K; Delagnon Kueviakoe, IM; Giraudier, S; Layibo, Y; Padaro, E; Sanogo, I; Segbena, AY; Vovor, A	1
Gilliland, DG; Tefferi, A	1
Amitrano, L; Brancaccio, V; Colaizzo, D; Grandone, E; Guardascione, MA; Margaglione, M; Scenna, G; Tiscia, GL	1
Constantinescu, SN; Elliott, J; Hookham, MB; Johnston, JA; McMullin, MF; Percy, MJ; Staerk, J; Suessmuth, Y; Vainchenker, W; Ward, AC	1
Andrikovics, H; Csukly, Z; Halm, G; Király, V; Lovas, N; Lueff, S; Masszi, T; Mátrai, Z; Meggyesi, N; Mikala, G; Nahajevszky, S; Sipos, A; Szilvási, A; Tamáska, J; Tordai, A	1
Carnley, B; Hammond, E; Herrmann, R; James, I; P'ng, S; Shaw, K	1
Chen, Q; Cross, NC; Jones, AV; Lu, P; Silver, RT; Wang, YL	1
Bödör, C; Csernus, B; Csomor, J; Matolcsy, A; Rajnai, H; Reiniger, L; Szepesi, A; Timár, B	1
Dirnhofer, S; Hao-Shen, H; Looser, R; Schwaller, J; Skoda, RC; Sobas, MA; Tiedt, R	1

Reviews

2 review(s) available for phenylalanine and Myeloproliferative Disorders

Article	Year
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood, 2009, May-28, Volume: 113, Issue:22 Topics: Algorithms; Amino Acid Substitution; Biomarkers, Tumor; Case-Control Studies; Early Detection of Cancer; Female; Gene Frequency; Humans; Janus Kinase 2; Male; Myeloproliferative Disorders; Neoplasms; Phenylalanine; Philadelphia Chromosome; Point Mutation; Valine; Venous Thromboembolism	2009
The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis. Mayo Clinic proceedings, 2005, Volume: 80, Issue:7 Topics: Algorithms; Diagnosis, Differential; Humans; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Phenylalanine; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Signal Transduction; Valine	2005

Article

Year

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.

Blood, 2009, May-28, Volume: 113, Issue:22

Topics: Algorithms; Amino Acid Substitution; Biomarkers, Tumor; Case-Control Studies; Early Detection of Cancer; Female; Gene Frequency; Humans; Janus Kinase 2; Male; Myeloproliferative Disorders; Neoplasms; Phenylalanine; Philadelphia Chromosome; Point Mutation; Valine; Venous Thromboembolism

2009

The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis.

Mayo Clinic proceedings, 2005, Volume: 80, Issue:7

Topics: Algorithms; Diagnosis, Differential; Humans; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Phenylalanine; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Signal Transduction; Valine

2005

Other Studies

23 other study(ies) available for phenylalanine and Myeloproliferative Disorders

Article	Year
Broken heart syndrome triggered by an obstructive goiter not associated with thyrotoxicosis. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2013, Volume: 60, Issue:8 Topics: Aged; Airway Obstruction; Echocardiography; Female; Goiter, Nodular; Goiter, Substernal; Heart Failure; Humans; Intra-Aortic Balloon Pumping; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Phenylalanine; Respiratory Insufficiency; Takotsubo Cardiomyopathy; Tracheal Stenosis; Valine	2013
Determination of accuracy of polycythemia vera diagnoses and use of the JAK2V617F test in the diagnostic scheme. Annals of hematology, 2014, Volume: 93, Issue:9 Topics: Amino Acid Substitution; Diagnostic Errors; DNA Mutational Analysis; Genetic Testing; Humans; Janus Kinase 2; Mutation, Missense; Myeloproliferative Disorders; Phenylalanine; Polycythemia Vera; Registries; Retrospective Studies; Sensitivity and Specificity; Valine	2014
Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN. Blood, 2015, Mar-26, Volume: 125, Issue:13 Topics: Amino Acid Substitution; Animals; Bone Marrow; Bone Marrow Neoplasms; Disease Models, Animal; Disease Progression; Gene Deletion; Hematopoietic Stem Cells; Janus Kinase 2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloproliferative Disorders; Phenylalanine; STAT3 Transcription Factor; Thrombocytosis; Valine	2015
Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting. Journal of clinical laboratory analysis, 2016, Volume: 30, Issue:6 Topics: Case-Control Studies; DNA Mutational Analysis; Female; Genotype; Humans; Janus Kinase 2; Male; Myeloproliferative Disorders; Phenylalanine; Polymorphism, Single Nucleotide; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Valine	2016
Concordance of assays designed for the quantification of JAK2V617F: a multicenter study. Haematologica, 2009, Volume: 94, Issue:1 Topics: Calibration; Cell Line; DNA; Humans; Janus Kinase 2; Myeloproliferative Disorders; Phenylalanine; Polymerase Chain Reaction; Reference Standards; Reproducibility of Results; Valine	2009
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F. Blood, 2009, Feb-26, Volume: 113, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Chromosome Deletion; Chromosomes, Human, Pair 20; Clone Cells; Comparative Genomic Hybridization; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Phenylalanine; Valine	2009
Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. Journal of leukocyte biology, 2009, Volume: 85, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Amino Acid Substitution; Animals; Cell Line, Transformed; Cell Proliferation; Enzyme Activation; Hematopoietic System; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Membrane Proteins; Mice; Mutant Proteins; Myeloid Cells; Myeloproliferative Disorders; Phenylalanine; Protein Binding; Protein Structure, Tertiary; Proteins; Valine	2009
Analysis of the progression of JAK2 V617F positive myeloproliferative neoplasms by single-nucleotide polymorphism array does not reveal a strong chromosomal instability. Cancer genetics and cytogenetics, 2009, Jul-15, Volume: 192, Issue:2 Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Chromosomal Instability; Disease Progression; Humans; Janus Kinase 2; Middle Aged; Myeloproliferative Disorders; Phenylalanine; Polymorphism, Single Nucleotide; Valine	2009
A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm. Leukemia research, 2010, Volume: 34, Issue:4 Topics: Aged, 80 and over; Amino Acid Substitution; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Janus Kinase 2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myeloproliferative Disorders; Phenylalanine; Piperazines; Pyrimidines; Thrombocytosis; Valine	2010
Alternately binding probe competitive PCR as a simple, cost-effective, and accurate quantification method for JAK2V617F allele burden in myeloproliferative neoplasms. Leukemia research, 2011, Volume: 35, Issue:12 Topics: Alleles; Amino Acid Substitution; Binding, Competitive; Bone Marrow Neoplasms; Cell Line, Tumor; Cost-Benefit Analysis; DNA Mutational Analysis; DNA Probes; Gene Dosage; Humans; Janus Kinase 2; Models, Biological; Myeloproliferative Disorders; Phenylalanine; Polymerase Chain Reaction; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Valine	2011
JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms. Leukemia research, 2012, Volume: 36, Issue:1 Topics: Bone Marrow Neoplasms; Case-Control Studies; Fusion Proteins, bcr-abl; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Janus Kinase 2; Mesenteric Vascular Occlusion; Mesenteric Veins; Mutation; Myeloproliferative Disorders; Phenylalanine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Splanchnic Circulation; Valine; Venous Thrombosis	2012
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia]. Orvosi hetilap, 2011, Nov-06, Volume: 152, Issue:45 Topics: Adult; Aged; Bone Marrow Neoplasms; Chronic Disease; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Phenylalanine; Polycythemia Vera; Polymerase Chain Reaction; Predictive Value of Tests; Primary Myelofibrosis; Retrospective Studies; Signal Transduction; Thrombocythemia, Essential; Thrombosis; Valine	2011
The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow. Neoplasia (New York, N.Y.), 2011, Volume: 13, Issue:11 Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Bone Marrow Cells; Bone Marrow Neoplasms; Cell Transformation, Neoplastic; Cells, Cultured; Drug Evaluation, Preclinical; Janus Kinase 2; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloproliferative Disorders; Phenylalanine; Protein Kinase Inhibitors; Stilbenes; Valine	2011
Characterization and discovery of novel miRNAs and moRNAs in JAK2V617F-mutated SET2 cells. Blood, 2012, Mar-29, Volume: 119, Issue:13 Topics: Amino Acid Substitution; Base Sequence; Cell Line, Tumor; Cloning, Molecular; Gene Expression Regulation, Neoplastic; Genetic Heterogeneity; Humans; Janus Kinase 2; MicroRNAs; Molecular Sequence Data; Mutation; Myeloproliferative Disorders; Phenylalanine; RNA Isoforms; RNA Precursors; Valine	2012
Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice. Blood, 2012, Apr-12, Volume: 119, Issue:15 Topics: Amino Acid Substitution; Animals; Bone Marrow Neoplasms; Cell Transformation, Neoplastic; Genes, abl; HEK293 Cells; Humans; Janus Kinase 2; Mice; Mice, Congenic; Mice, Inbred BALB C; Mice, Transgenic; Mutation, Missense; Myeloproliferative Disorders; NIH 3T3 Cells; Phenylalanine; STAT5 Transcription Factor; Valine	2012
[Myeloproliferative disorders "Philadelphia negative" and JAK2V617F mutation: study of 15 cases in Togo]. Annales de biologie clinique, 2012, Oct-01, Volume: 70, Issue:5 Topics: Adult; Aged; Amino Acid Substitution; Cohort Studies; Female; Humans; Janus Kinase 2; Longitudinal Studies; Male; Middle Aged; Mutation, Missense; Myeloproliferative Disorders; Phenylalanine; Philadelphia Chromosome; Prognosis; Togo; Valine	2012
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cohort Studies; Female; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Humans; Italy; Janus Kinase 2; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Middle Aged; Mutation; Myeloproliferative Disorders; Odds Ratio; Phenylalanine; Portal Vein; Risk Factors; Time Factors; Valine; Venous Thrombosis; Von Hippel-Lindau Tumor Suppressor Protein	2007
The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood, 2007, Jun-01, Volume: 109, Issue:11 Topics: Animals; Erythropoietin; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Leukocytes, Mononuclear; Mice; Mutation; Myeloproliferative Disorders; Phenylalanine; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Valine	2007
[Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection]. Orvosi hetilap, 2007, Feb-04, Volume: 148, Issue:5 Topics: Adult; Aged; Biopsy; Bone Marrow; Female; Gene Expression Regulation; Gene Frequency; Humans; Janus Kinase 2; Male; Middle Aged; Myeloproliferative Disorders; Phenotype; Phenylalanine; Point Mutation; Polycythemia Vera; Polymerase Chain Reaction; Primary Myelofibrosis; Thrombocytosis; Valine	2007
Quantitative determination of JAK2 V617F by TaqMan: An absolute measure of averaged copies per cell that may be associated with the different types of myeloproliferative disorders. The Journal of molecular diagnostics : JMD, 2007, Volume: 9, Issue:2 Topics: Amino Acid Substitution; Case-Control Studies; Gene Dosage; Humans; Janus Kinase 2; Myeloproliferative Disorders; Phenotype; Phenylalanine; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Valine	2007
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders. The Journal of molecular diagnostics : JMD, 2007, Volume: 9, Issue:2 Topics: Chronic Disease; DNA Mutational Analysis; Exons; Genetic Testing; Genome, Human; Humans; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Phenylalanine; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Valine	2007
[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Orvosi hetilap, 2006, Nov-12, Volume: 147, Issue:45 Topics: Alleles; Amino Acid Sequence; Base Sequence; Biomarkers, Tumor; Genetic Markers; Humans; Janus Kinase 2; Leukemia; Molecular Sequence Data; Myeloproliferative Disorders; Phenylalanine; Point Mutation; Polycythemia Vera; Polymerase Chain Reaction; Primary Myelofibrosis; Signal Transduction; Thrombocytopenia; Valine	2006
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Blood, 2008, Apr-15, Volume: 111, Issue:8 Topics: Animals; Colony-Forming Units Assay; Granulocytes; Hematopoiesis, Extramedullary; Humans; Hyperplasia; Integrases; Janus Kinase 2; Megakaryocytes; Mice; Mice, Transgenic; Mutant Proteins; Myeloproliferative Disorders; Phenotype; Phenylalanine; Polycythemia Vera; Primary Myelofibrosis; Recombination, Genetic; Thrombocythemia, Essential; Transgenes; Valine	2008